A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate

被引：0
|
作者：
Milan Zdravkovic
Anette K. Olsen
Tina Christiansen
Rainer Schulz
Mitchell E. Taub
Mikael S. Thomsen
Michael H. Rasmussen
Mapoko M. Ilondo
机构：
[1] Research and Development,Novo Nordisk A/S
[2] Department of Clinical Drug Development,Novo Nordisk A/S
[3] Quintiles Innovex (Biodesign),undefined
来源：
European Journal of Clinical Pharmacology | 2003年 / 58卷
关键词：
CYP3A4; Interaction; Midazolam; NN703; Clinical study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：683 / 688
页数：5
相关论文
共 50 条
  • [31] Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinide
    Lauri I. Kajosaari
    Tiina Jaakkola
    Pertti J. Neuvonen
    Janne T. Backman
    European Journal of Clinical Pharmacology, 2006, 62 : 217 - 223
  • [32] Inhibitory Effects of Vegetable Juices on CYP3A4 Activity in Recombinant CYP3A4 and LS180 Cells
    Tsujimoto, Masayuki
    Uchida, Tomoe
    Kozakai, Hiroyuki
    Yamamoto, Saori
    Minegaki, Tetsuya
    Nishiguchi, Kohshi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (09) : 1482 - 1487
  • [33] CYP3A4 HUMANIZED MOUSE; A MODEL TO STUDY CYP3A4-MEDIATED DRUG-DRUG INTERACTION POTENTIAL
    Rose, Anne
    Xu, Carrie
    Johnghar, Susan
    Behnia, Kamelia
    DRUG METABOLISM REVIEWS, 2012, 44 : 76 - 77
  • [34] MD Investigation on the Interaction between Carbamazepine and Two CYP Isoforms, CYP3A4 and CYP3A5
    Liu, Shuhui
    Xu, Yang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [35] Interaction of CYP3A4 with caffeine: First insights into multiple substrate binding
    Sevrioukova, Irina F.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (09)
  • [36] Substrate-dependent drug interaction with CYP3A4 irreversible inactivators
    Wang, RW
    Cai, XX
    Tang, W
    Edom, RW
    Didolkar, V
    Stearns, RA
    Evans, DC
    DRUG METABOLISM REVIEWS, 2002, 34 : 179 - 179
  • [37] Homology modelling of CYP3A4 from the CYP2C5 crystallographic template: analysis of typical CYP3A4 substrate interactions
    Lewis, DFV
    Lake, BG
    Dickins, M
    Goldfarb, PS
    XENOBIOTICA, 2004, 34 (06) : 549 - 569
  • [38] Effect of influenza immunization on CYP3A4 activity
    Hayney, MS
    Hammes, RJ
    Fine, JP
    Bianco, JA
    VACCINE, 2001, 20 (5-6) : 858 - 861
  • [39] Effect of CYP3A4*22 and CYP3A4*1B but not CYP3A5*3 polymorphisms on tacrolimus pharmacokinetic model in Tunisian kidney transplant
    Hannachi, Ibtissem
    Ben Fredj, Nadia
    Chadli, Zohra
    Ben Fadhel, Najah
    Ben Romdhane, Haifa
    Touitou, Yvan
    Boughattas, Naceur A.
    Chaabane, Amel
    Aouam, Karim
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 396
  • [40] Effect of NIPRISANA® on CYP3A4 activity in vitro
    Adzu, Bulus
    Masimirembwa, Collen
    Mustapha, Kudirat Bola
    Thelingwani, Roslyn
    Kirim, Rukaiyatu Abdullahi
    Gamaniel, Karniyus Shingu
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2015, 40 (01) : 115 - 118
12345